Compositions for sensitive skin

US10245282B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10245282-B2
Application numberUS-201715796958-A
CountryUS
Kind codeB2
Filing dateOct 30, 2017
Priority dateNov 22, 2013
Publication dateApr 2, 2019
Grant dateApr 2, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are compositions and methods for their use that include a combination of hydrolyzed algin, escin, Ruscus aculeatus root extract, ammonium glycyrrhizate, Centella asiatica extract, hydrolyzed yeast protein, and Calendula officinalis flower extract.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of treating erythemic skin of a human in need thereof, the method comprising topically applying to the erythemic skin of said human in need thereof a composition comprising a therapeutically effective amount of: (a) hydrolyzed algin; (b) escin; (c) Ruscus aculeatus root extract; (d) ammonium glycyrrhizate; (e) Centella asiatica extract; (f) hydrolyzed yeast protein; and (g) Calendula officinalis flower extract. 2. The method of claim 1 , wherein the composition reduces pro-inflamatory cytokine productin in the skin, and wherein the pro-inflammatory cytokine is TNF-a, IL-6, IL-8, IL-10, IL-12 p40, or GM-CSF. 3. The method of claim 1 , further comprising between 80 to 90% by weight of water. 4. The method of claim 1 , wherein said composition comprises: (a) 0.005 to 0.05% by weight of hydrolyzed algin; (b) 0.001 to 0.05% by weight of escin; (c) 0.001 to 0.01% by weight of Ruscus aculeatus root extract; (d) 0.001 to 0.01% by weight of ammonium glycyrrhizate; (e) 0.0005 to 0.005% by weight of Centella asiatica extract; (f) 0.0003 to 0.003% by weight of hydrolyzed yeast protein; and (g) 0.0003 to 0.003% by weight of Calendula officinalis flower extract. 5. The method of claim 1 , wherein the composition further comprises butylene glycol; glycerin; propylene glycol; diazolidinyl urea; PPG-5-ceteth-20; methylparaben; sodium citrate; disodium EDTA; buteth-3; propylparaben; citric acid; sodium benzotriazolyl butylphenol sulfonate; and panthenol. 6. The method of claim 1 , wherein the composition further comprises glycerin; pentylene glycol; glycereth-26; propylene glycol; triethanolamine; acrylates/C10-30 alkyl acrylate crosspolymer; diazolidinyl urea; hydroxy ethylcellulose; sodium polyacrylate; methylparaben; disodium EDTA; butylene glycol; phenoxy ethanol; caprylyl glycol; propylparaben; and panthenol. 7. The method of claim 1 , wherein the composition further comprises pentylene glycol; polysilicone-11; hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer; dimethicone; squalane; glyceryl undecylenate; silica; butylene glycol; triethanolamine; polysorbate 60; acrylates/C10-30 alkyl acrylate crosspolymer; hydroxypropyl cyclodextrin; sorbitan isostearate; panthenol; and glycerin. 8. The method of claim 1 , wherein the composition further comprises glycerin; pentylene glycol; glycereth-26; benzyl alcohol; triethanolamine; acrylates/C10-30 alkyl acrylate crosspolymer; hydroxy ethylcellulose; sodium polyacrylate; di sodium EDTA; hydroxypropyl cyclodextrin; butylene glycol; phenoxy ethanol; caprylyl glycol; and panthenol.

Assignees

Inventors

Classifications

  • Preparations for sensitive skin · CPC title

  • A61K8/733Primary

    Alginic acid; Salts thereof · CPC title

  • Steroids; Derivatives thereof · CPC title

  • Cactaceae (Cactus family), e.g. pricklypear or Cereus · CPC title

  • Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10245282B2 cover?
Disclosed are compositions and methods for their use that include a combination of hydrolyzed algin, escin, Ruscus aculeatus root extract, ammonium glycyrrhizate, Centella asiatica extract, hydrolyzed yeast protein, and Calendula officinalis flower extract.
Who is the assignee on this patent?
Mary Kay Inc
What technology area does this patent fall under?
Primary CPC classification A61K8/733. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).